# data[].attributes.body
My top five strengths are as follows: Relator, Command, Restorative, Individualization, Self-Assurance.

My team:

Angelica- analytical. I need someone on the team to think through and assess all possible reasons and causes of our innovation and include all factors in our decision.

David - deliberative. David will be strategic in  assessing all possible obstacles and bringing a level of seriousness to the task at hand which will help us in our thorough evaluation of the product.

Louis - learner.  Adding Louis to our team will help to guarantee that we are looking at this from the perspective of the person that has to use it and be taught how to use it. We will need leverage not only his love of learning but his excitement for the outcome.

Abraham - arranger. Abraham will be key in our ability to put all the moving parts and pieces together for a convincing presentation. We will need his organizational skills but also his ability to be flexible and highlight the positives from man different perspectives.

William - woo. We will need William when it is time to not only bring this innovation to the clinical teams and help with buy in of staff to trust the product but also in leveraging our request to administration as there is surely high cost involved. William will be able to connect with key players outside of just presenting facts.

# data[].attributes.body
ivWatch, Breakthrough in IV Safety (Report Number: Rev. 4-7 18) [White Paper] Retrieved from:
https://www.ivwatch.com/wp-content/uploads/2018/05/Model-400-Whitepaper-Rev-4-718.pdf

ivWatch Monitors iv placement sites for leakage outside veins. (2015, April 9) Retreived September 30,2018 from
https://www.medgadget.com/2015/04/ivwatch-monitors-iv-placement-sites-for-leakage-outside-veins.html

ivWatch now available for continuous iv monitoring?  (2016, April 8) FDA News Device Daily Bulletin. Retrieved from
https://www.fdanews.com/articles/176061-ivwatch-now-available-for-continuous-iv-monitoring?
utm_source=TrendMD&utm_medium=cpc&utm_campaign=Device_Daily_Bulletin_TrendMD_0

R.E. Helm, J.D. Klausner, J.D. Klemperer, L.M. Flint, and E. Huang, “Accepted but Unacceptable: Peripheral IV Catheter
Failure,” Journal of Infusion Nursing, vol. 38, no. 3, May/June 2015.

# data[].attributes.body
I find this innovation intriguing and potentially practice changing if it works as well as the studies reflect. As stated IV therapy is incredibly common in the hospital setting and while it is simple, it can be a frustrating, anxiety producing and at times a dangerous therapy. This product seems to provide an intervention for the nurse monitoring and IV site hourly which can be inconsistent depending their patient load.  This product could have appeal to both bedside staff and management alike in it's ability to reduce costs associated with infiltrations as well as improved employee satisfaction.  I was unable to find a cost analysis and would be interested in comparing the cost of bringing this product into a hospital, with all of the associated staff education, to the cost of IV infiltration including the wasted medications as well as the cost of potential surgeries to the affected tissue. It seems this product works well with peripheral IV's and I would also be interested in further product development specifically around infiltrations related to ports and vesicant drugs such as many chemotherapy medications. Overall this is something that I would be very interested in bringing into my current institution.

# data[].attributes.body
1. Additional equipment to maintain, become competent in and incorporate into daily practice.

2. Could provide a false sense of security, replacing the tried and true hourly rounding and device check

3. Additional tubing and cords that could impede especially pediatric patients ability to be active or prevent parents from getting close to their child

4.  Adds additional alarms in an already alarm heavy environment.

5. Is only compatible with the Phillips monitoring systems rather than the many other such as SpaceLabs, GE and Mindray.

# data[].attributes.body
1. Potentially a more objective tool to detect IV infiltration.

2.  Could improve patient safety by leading to a reduction of injury to the affected limb  which in turn would safe healthcare institutions money and time.

3. Medications are costly and every infiltration is essentially a medication error this could potentially reduce wasted medication.

4. Provide peace of mind and confidence to the nurse that the IV is working appropriately and that the IV pump is delivering medication safely into the vein and not the surrounding tissue.

5. Highly regarded and awarded in the technology sector as a strong product providing confidence to users

# data[].attributes.body
Multiple studies performed  some specifically on pediatric and neonate patients were noted in the ivWatch company whitepaper (2018). Studies varied from early state detection of infiltration, rate of infiltration to infiltration detection,  and effect  alarm fatigue on clinical detection of IV infiltration
Results:

1. Notifications on ivWatch were effective indicators of IV infiltration and early detection of infiltration.

2.  Device worked effectively regardless of variances such has skin pigmentation, body type and mass and infiltration rates.

3. ivWatch monitor detected infiltration rates prior to clinical confirmation 80% of the time.

4. Rates of inaccurate red and yellow alarms were statistically small indicating an insignificant impact on alarm fatigue.

# data[].attributes.body
Peripheral intravenous (IV) catheter insertion, the most common invasive hospital procedure performed worldwide, is associated with a variety of complications and an unacceptably high overall failure rate of 35% to 50% in even the best of hands"  Helm et al (2015).

Any nurse could testify to the necessity of intravenous catheters (IV's) as well as the frustrations that go along with them.  Nurses know that placing and IV is painful and often times anxiety producing, now add that to a medication that has infused improperly into the subcutaneous tissue because the IV went bad and the whole process of placing and IV has become twice as time consuming, anxiety producing and frustrating for everyone.  This product has been cleared for use in both adult and pediatric populations but for this project I am focusing on pediatric patients.

Aside from the general frustration and anxiety surrounding IV insertion and care, IV infiltration's can cause serious damage to patient limbs as well as have life altering consequences such as limb amputation  (ivWatch White Paper 2018)

# data[].attributes.body
How it works for both Adult and Pediatric Patients

# data[].attributes.attachment_link.title
ivWatch Model 400 Product Overview For Adult and Pediatric Patients

# data[].attributes.headline
ivWatch  Model 400: Continuous Monitoring of Intravenous Fluid 

# data[].attributes.subject
ivWatch  Model 400: Continuous Monitoring of Intravenous Fluid 

# data[].attributes.body
- Developed by ivWatch
- Approved by FDA 2015
- Published by MedGadget in April, 2015 https://www.medgadget.com/2015/04/ivwatch-monitors-iv-placement-sites-for-leakage-outside-veins.html